웹2016년 12월 21일 · The reviewed studies involved a total of 1111 participants with ages ranging from 10 to 80 years old with eight clinical trials limiting participants to ≥40 years old [38, 61, 66, 68–70, 72, 75].Only three clinical trials included 100 or more participants [65, 66, 82].The study durations ranged from 2 to 13 weeks and tulsi dosage and frequency varied … 웹Andrew Bradbury (Birmingham, UK) reported that a new randomised controlled trial, BASIL 2, has been launched because there is an “urgent need” to undertake pragmatic, scientifically robust and publically-funded randomised controlled trials of endovascular interventions in patients with severe limb ischaemia.Bradbury stated that the findings of BASIL 1, which …
Comparison of Immediate and Long-term Outcomes in Men and …
웹1. Tulsi treats stomach ulcers. A 2024 study from Nigeria’s Nnamdi Azikiwe University tested 63 ulcer patients with holy basil oil with coconut oil or a placebo for four weeks alongside antibiotics (typical treatment). The researchers found the holy basil oil helped eradicate H. pylori and resolve the ulcer symptoms including pain. 웹1일 전 · BASIL-2 is an individually randomised, multi-centre, pragmatic, two-arm, open trial of two alternative revascularisation strategies: VB first vs. Best Endovascular Treatment (BET) first, for the management of SLI due to infra-politeal disease, with or without the presence of femoro-politeal, disease. The trial incorporates an internal pilot ... high risk ob johnson city
Basil I - World History Encyclopedia
웹2005년 12월 3일 · Background: The treatment of rest pain, ulceration, and gangrene of the leg (severe limb ischaemia) remains controversial. We instigated the BASIL trial to compare … 웹2024년 8월 28일 · BASIL-1 Trial • Still the only RCT! • NIHR HTA funding 1998 • Between 1999 and 2003 • 452 SLI patients randomised : • Bypass first (25% prosthetic) • PBA first (6 stents) • 75% femoro-popliteal • After 2 years –(vein) bypass better than PBA in terms of: • Amputation free survival • Overall survival • Quality of revascularisation 웹Introduction - Despite the only available level 1 evidence (from the UK NIHR HTA- funded BASIL-1 trial, B-1) showing superior outcomes from bypass, in recent years, there has been an increasing trend towards offering endovascular revascularisation (ER) to patients with severe limb ischaemia (SLI). This is frequently justified by asserting that the results of ER … how many calories should i burn a day walking